Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I understand your desire to hear more news; I truly do. However, I respect Bret's decision to avoid fluff PRs.
For those of you who have followed NNLX for 2+ years, you might recognize my screen name (although I have posted very little in the past year). A couple years ago, I was very vocal and critical when the Nutmeg financing was announced, and additionally, when there was a proposal to spilt the nanotechnology and hydrogen parts of the company into two separate entities, I nearly sold all my stock. However, Bret stepped in and, in my humble opinion, prevented a pillaging of this company.
Furthermore, upon taking over as CEO, Bret promised to make the financials transparent, which he did. He also promised stockholder updates, which he does. The updates might not be as frequent as some would like, but he is and has been true to his word. That in itself is a rarity for pinksheets.
Excellent news!
I just wanted to touch base and let everyone know I am still holding long and strong.
Go NNLX.
I’ve been away from the board, so I am now just getting caught back up. You guys have been busy recently! Also, what an excellent PR yesterday.
1) "We continue to operate the Welch's experimental system and are producing hydrogen daily” and “[w]e also project installation of a prototype Bioreactor at the Erie Wastewater Treatment Plant in Spring 2008.”
This is a brief but effective update on the bioreactor plans.
2) "This work is funded solely by NanoLogix, Inc."
Do not underestimate the power of this statement. This means no more dilutive, predatory financing. This means we have a CEO who cares about the shareholders and does not want to “give away” shares. My hunch is that governmental funding/grants are on the horizon. While I have no “proof” of that, with the potential of NNLX’s hydrogen technology, NNLX should clearly be a top contender for such grants.
3) “Sergey Gazenko, Ph.D. has renewed his contract with NanoLogix” and “Thomas A. Kelly, Ph.D. has rejoined NanoLogix as a consultant…”
Biotech continues to be a substantial part of this company. Shareholders should not overlook that potential. In fact, the biotech side seems to be the key to revenue at this time.
4) “NanoLogix has recently applied for a grant for funding of Bioreactor research from the United States Department of Agriculture”
That’s the way Bret. Grants should be a viable financing option for NNLX.
5) “This reduction in stock compensation was the first action by the CEO and the Board of Directors taken upon the change in Company management in March --- an action taken in the interest of reducing dilution of shareholder equity. Our goal is to reduce stock compensation by an additional 50% this year. In addition, Mr. Barnhizer and Mr. Allen wish to announce that they have and continue to hold shares purchased on the open market over time in the following amounts: Mr. Barnhizer, 2,030,000 shares since 09/2005; and Mr. Allen, 632,000 shares since 07/2006.”
Very few pinkies have this kind of transparency with their “Powers That Be” and their stock compensation. To me, this states that with or without SEC fully reporting status, Bret is planning to be transparent on some key issues. Once again, this is NOT common with most pinkies, and I am encouraged by the changes/progress this management has made.
As for the postings regarding the need for in-depth financials and outstanding share amounts, etc., I too want that information. However, I doubt these figures are stellar by any means. If you want stellar financials, do not play the pinkies. This company is about potential, pure and simple.
The mode of operation changed in March 2007, when the new management team took over, and it takes time to “right the course.” All I have asked (and griped for, at times) is that management makes good faith efforts to communicate. Bret is now doing that.
Thanks so much for posting this Parents, and THANK YOU Bret. This kind of PR was exactly what I wanted!
The key points for me are as follows:
1) Not only does NNLX have viable technology, they are in the process of building a viable product (the BioNanoChannel(TM)). This transition is a key step toward revenue growth.
2) The stand alone office is another hint to expected growth.
3) Cutting costs by 50% and increasing R&D 100% also indicates a desire to stop bleeding the company, and instead, create more growth opportunities. However, in all fairness, numbers like this are still quite vague since 50% and 100% can be substantial or minimal depending on the starting numbers. Once NNLX is off the pinks, figures like this will be very important to monitor.
4)"We look forward to the results of our team effort and the establishment of a strong revenue stream for the company from those efforts." That's music to my ears. Good management is concerned with revenue, not just technology. Again, I like Bret's focus here.
5)"The agreement with Randall S. Goulding and Associates to represent NanoLogix as corporate counsel has been terminated by the company." Woohoo! Bye-bye! Don’t let the door hit ya… (Randall S. Goulding is affiliated with the Nutmeg Group for those who might not know).
6) There is the promise of more updates.
Again, I cannot say how pleased I am with this PR. Please keep these coming Bret, as they are the main avenue to credible information for this company.
Jean--
When a pinksheet company goes for several months without news and has a list of promises made but little evidence of promises kept, the stock price goes down or is in the unfortunate circumstance that allows it to go down rather easily. I will give you that reasoning and fully understand any stockholders displeasure in those facts.
However, to state this is a scam stock is outright bashing; therefore, do not slam on what you see as "pumping" when your last post was a blatant bash. The amount and type of patents this company owns seems quite valid to me. Additionally, it is highly doubtful a scam stock would work with a company with name recognition like Welch's (not to mention political recognition like the city of Erie). Remember that the mayor of Erie was quoted in the NNLX PR about the wastewater bioreactor. Logic states he does not think this company is a scam. Additionally, Bret has stated he is firmly against the detrimental and dilutive financing that has been done in the past.
That being said, I am not pleased at all with the silence and share price, so I understand the frustration. However, I am with Gun on this one. I will either go broke on this investment or start looking to sell around the $1.00 range (this is my first target; I will reassess if/when NNLX gets to that level).
One last note, the website is all fine and dandy, but there are two very intriguing new bits of information: 1) They are moving their main offices to Ohio. I take this as a good sign since there must be a reason for doing so. Also, I drive right by this city on my travels between Ohio and PA, so I might just check out the building on my next trip. 2) They are actively pursuing governmental grants. This is wonderful news, in my opinion. NNLX seems ripe with potential for receiving governmental grants, not only with their hydrogen production potential but also with their biomedical diagnosis nanotechlogy. Grants would allow the company to gain governmental recognition along with non-dilutive financing.
Without substantial news and information, however, the stock price will continue to flounder. No one should be surprised at that.
Rocket--
I completely agree with your statement "I respect Bret's silence more than the other guy's bogus claims and deadlines." Fluff PRs and "pie in the sky" promises do not serve any credible pink sheet stocks.
However, Bret promised updates to keep the shareholders informed. I do not have the time at the moment to find his exact post on this, but his stated intention was to provide updates to shareholders every few weeks or so. While he hopefully is succeeding in various other areas of NNLX's operations, he is not succeeding in keeping shareholders informed at this time.
I will continue to hold for the long-term, as NNLX possesses some amazing technology, but new shareholders will not be attracted until viable transparency is offered for this company.
I agree Gun.
Most of us have been patient and know transitions in management take time. I respect that and truly feel as if Bret has the company's and shareholders' best interest in mind. However, "feeling it" and seeing proof are two completely different things. Bret promised he would keep stockholders informed; that, in my opinion, has not been happening.
"Hey Smeagle, I guess the lava didn't finish you off."
LMAO. Good one Nmbr1.
"My preccccciiious!" :)
Thanks EiK.
When the stock price feels pressure, shareholders understandably get twitchy. Therefore, I appreciate the brief, public update.
Also, I agree with Vinnie. NNLX does not seem to be a typical pinkie. With Nutmeg's involvement, I feared it was, but with the managment change in February, I am more positive than ever (regardless of the stock price).
Perhaps my approach to watching this stock would be helpful to some. As a traditional swing trader, holding a stock this long is not natural for me (although I have held long on a couple stocks over the years). In essence, there are three main reasons why I do not watch this board or this stock every day:
1) Watching this stock every day will drive me crazy (okay, that's a very personal reason!). :)
2) As with any stock with "new" technology, it takes time before the public fully notices it. Honestly, look at the history of most "new" technology stocks and notice how the wick burns for quite a time before things really light up.
3) Most imporantly, becoming a holder of this stock for over a year will result in any stock sale being subject to long-term capital gains vs. short-term capital gains. With a stock with this potential, that could translate into a large amount of money.
Keep working the plan EiK. I do hope NNLX gets the attention it deserves.
First of all, I would like to say thank you to all who are contributing to this honest discussion. Once again, this is unique (in my experience) to pinksheet boards which are often filled with pure pumpers or bashers, Also, Abew4me brings up some important points to consider.
In general, here are some of my thoughts. Based on my research, I do not think ethanol is the long-term answer to our fossil fuel problem. However, the ethanol solution sounds great in political arenas. After all, it keeps more money in the hands of Americans (or allies of America), it empowers farmers, and quite frankly, ethanol will create jobs (in fact, an ethanol plant will soon be built on the outskirts of the town where I grew up in Ohio. With the loss of numerous blue-collar jobs in that area, this is big and welcome news indeed). That being said, there are cost and ethical concerns (using food for fuel) with ethanol which could be problematic in the future.
I am a believer in the hydrogen solution for the long term. As another poster previously mentioned, hydrogen production with methane results in the dilemma of how to “get rid" of the methane. In our current "green" mindset, this could be a strong negative as too much CO2 production is not “healthy” for our environment. NNLX, to my knowledge, is the leader is producing hydrogen without methane. Despite questions about production levels and the ability to transport hydrogen, their stated technology is the best I have researched.
The key to NNLX's success, in my opinion, is not becoming a "good idea" that was overrun by other companies with "good ideas." In other words, its ability to partner with a well-known energy company that can provide both funding and public relations is a must. Past PRs and interviews have implied this is in the works for NNLX, but I understand investors being hesitant until any formal announcement is made.
As I've stated before, NNLX has a great amount of potential, and I am willing to invest some of my money based on that potential (remember the "unproven" nature of this company is why the stock has traded between .10-.20 for nearly a year).
Parents--I happen to agree with your general reasoning.
By all means, I do not know how many shares The Nutmeg Group received for their $750,000 financing, but there is little doubt the amount was substantial. Additionally, EnergyisKing alluded to another insider who had separated from the company and who would be liquidating shares. This logic is further supported by the trading patterns after PRs. Earlier this year, any spikes in share price seemed to be met with an abundance of shares for sale.
That being said, I do not think NNLX is deliberately withholding any PRs, etc. to keep the share price down. Instead, I attribute the limited number of PRs to reflect the "new" style of NNLX management. In other words, there now seems to be a hesitance to release "fluff" PRs filled with promises. Instead, they seem to be waiting to release the information after certain tasks have been completed. Again, in the world of pink sheet stocks, this is a welcome and positive trend.
Also, note the new management team took place after the failed split off of the biomedical portion of NNLX; therefore, it will take a little time before the current management team shows evidence of their work. However, based on previous PRs and published interviews, I am expecting a few very important announcements by the end of the year:
1) A move to the OTC (at minimum)
2) A biomedical announcement (this could be tied to the patent NNLX filed earlier this year)
3) Some type of working relationship or interest from a Fortune 500 company (this will most likely involve the hydrogen side of NNLX).
There are no guarantees, of course, but NNLX is a pink sheet stock that clearly has potential, and I do not see this potential as "wishing thinking." However, in all fairness to the posters who might be skeptical, management does need to prove some of these promises are being fulfilled to instill greater investor confidence.
I think investors who have been around for over a year plan to hold until some of the promises are manifested. I know that's my gameplan.
While I tend to get impatient about hearing news, I completely respect Bret's desire to avoid fluff releases. That, in my opinion, is further indiction of positive changes in the company.
Some Thoughts
On Friday, I had a 60,000 share buy order at .115 that never filled. I can only hope that indicates an impending end to the share liquidation from NNLX's previous financing. I believe Bret, long before he became CEO, indicated the participants in the more recent financing planned to hold at least until the 1.00 - 2.00 range. Correct me if I am wrong, but I am 99.9% sure I read that in one of his previous posts.
Also, I still believe there is a pending biomedical announcement. This is based on the interviews conducted at the end of 2006 and the thwarted intent to "spin off" the biomedical interests from the hydrogen interests this past February.
If this announcement has anything to do with cancer, the timing could be quite interesting. Wall Street lately has been very excited about "cancer" stocks. Note the recent movement of DNDN and NUVO to name two (I am not recommending buying those stocks at all; I am simply noting Wall Street’s reaction to "cancer" stocks of late). That being said, I would rather NNLX have a consistent and prolonged rise in share price; however, the timing of a biomedical announcement addressing any positives regarding cancer treatment and/or identification would provide a good chance for some much needed PR.
I just have time for a quick note.
Here is a helpful link to listing requirements for various exchanges:
http://www.venturelawcorp.com/listing_requirement_master_chart.htm
I hope that helps.
My, oh my. While I was away, this stock board certainly became interesting.
First of all, congrats EiK on your new positions. I am pleased to see that.
As for new and cautious posters, I honestly respect your concerns regarding pink sheets and potential scams that run amok in the pinks. I rarely invest in the pinks due to those same reasons. I also respect any investor’s right to sell (or buy) shares based on his/her own DD.
However, there are some misunderstandings I would like to address. First, EiK (Bret Barnhizer) started posting long before he became Chairman of the Board, CEO, and President. Those are new positions to him, and he, in my opinion, is now addressing one of my biggest complaints with this company: a lack of communication with investors. As long as no inside information is provided (which it has not been), I appreciate the general information and updates.
Secondly, I was very outspoken toward the end of last year about the lack of "substantial" PRs. I had suspicions at the time that some members of the Nutmeg would try to "take over" control of Nanologix. One look at the Nutmeg Group's track record and the reverse merger of Hydrogensis/Inverso should make the picture pretty clear. The attempt to split off the main viable part of the company (the medical patents) without any clear guidelines regarding future dilution is further proof of this, in my opinion. In other words, I think this stock, while having very impressive potential, was quite close to being trampled for a few people's self interest.
Thirdly, and this is pure speculation based on deduction, I suspect Barnhizer's holdings, among others, played a substantial role in creating the managerial structure we now see. Thank goodness for that. That is also why my postings have been much more positive as of late.
Again, due your own DD and invest or don't invest as you see fit. However, it is short-sighted (and forgive me for being blunt--rather ignorant) to simply see EiK's posts as the CEO chatting it up on a message board.
Nmbr1--
IMHO, this volume is greatly helpful in churning the stock from some of the previous financial dealings to stronger, more long-term investors.
Excellent!
http://biz.yahoo.com/iw/070312/0225391.html
Although this PR does not state any "finalized" results, its mere existance marks a substantial (and very positive!) change for this company.
Thanks for the clarification EiK.
Hmmm...I found the same information Moe.
However, I hope that was an insightful slip. Based on recent interviews conducted at the end of 2006 and from the investors’ informational conference, some substantial biomedical news is pending.
I'd love to see NNLX receive the exposure and benefits from working with a larger pharmaceutical. Of course, this could simply be an honest slip (or perhaps my research fails me and there really is a Penwest Renewable Energy Conference), but it's fun to investigate anyway. Here's Penwest's company description:
Penwest Pharmaceuticals Co. develops pharmaceutical products based on proprietary drug delivery technologies primarily in North America. It develops products principally that address disorders of the nervous system.
http://finance.yahoo.com/q?d=t&s=PPCO
I could not agree more Parents.
One of the reasons I was so insistent on news at the beginning of the year was due to the Nutmeg Group's involvement in this stock. In fact, after the reverse merger of Inverso/Hydrogensis last September, I feared (and expected) some type of takeover/merger with Nanologix.
With the recent news regarding the new members on the board of directors, those concerns have dwindled. My hunch is that there are still a good number of "Nutmeg" shares ready to be dumped into the market on any uptick, but time and/or a substantial news release (perhaps regarding "life on Mars")will allow for that.
In any case, recent events have been very encouraging.
OT: That was great Dennis. Thanks for sharing. :)
Congrats EiK! I thank you for keeping the shareholders in mind and wish you (and Dana)all the best as new boardmembers. The weather does look brighter today.
Bret Barnhizer and Dana Allen Elected to NanoLogix Board of Directors
Tuesday February 27, 11:01 am ET
SHARON, PA--(MARKET WIRE)--Feb 27, 2007 -- NanoLogix, Inc. (Other OTC:NNLX.PK - News) announces the election of Bret Barnhizer and Dana Allen to its Board of Directors. Mr. Barnhizer will serve as Director-At-Large with Mr. Allen serving as Vice President of Strategic Partnering. The addition of Mr. Barnhizer and Mr. Allen expands the number of directors on the NanoLogix board to five.
ADVERTISEMENT
Bret Barnhizer
For more than 25 years, Bret Barnhizer has provided engineering, operations management, and project management services to Chevron, BP, Unocal, Occidental Petroleum, and others in the U.S., Europe, Africa, and Asia. Mr. Barnhizer has managed and been involved in projects of varied scope, ranging from 40 million to over 500 million dollars in value.
Dana Allen
Dana Allen has 26 years of business experience in numerous industries and sectors; Mr. Allen was the Founder, Chairman and CEO of Sequoia Data Corp. (1987-1996); Vice President then later Chairman, CEO and President of TMSSequoia (a public co.) (1996-1999) where he was granted 8 patents for various inventions; Co-Founder and Chairman of NewsMax (1998-2000), President of American Investigator Television (2000-2001). Mr. Allen is currently President of Sequoian Technologies, an invention creation and marketing firm whose primary business is to market patents by Mr. Allen and others in a broad range. The first patents to be filed relate to reducing emissions approximately 90% in 2-Stroke engines and a new 4 Stroke Engine Cycle method that will improve fuel economy.
"We are extremely pleased to welcome Bret and Dana to the NanoLogix Board of Directors," said CEO Mitchell Felder, M.D. "I anticipate that their individual professional experience, business acumen and personal integrity will enable them to contribute meaningfully to the further formation of our strategy and to serve NanoLogix shareholders well."
"I am excited to join the Nanologix team," said Director, Dana Allen. "It is the most technology rich company of its size I have ever seen. The Board is focusing on commercializing the company's valuable patents and technologies. We see the opportunity for these technologies having profound positive effects for the world in addition to their commercial value."
Although I am a bit late posting this, thank you so much for the meeting update EiK. I wish I could have been there.
Quite honestly, the recent turn of events (the decision to can the vague spin-off of the biomedical parts of NNLX and the attempt at forthright, specific communication) has been encouraging.
I have also noted a tug-of-war in NNLX. Some earlier financials dealings (the Nutmeg Group) and the OTC pump article (that's solely my opinion of it) and the limited specific information about the audit, partnerships, etc. had me questioning seriously whether or not I wanted to remain a shareholder.
However, management now seems to being looking forward from a business perspective in addition to a scientific/technological perspective. This, I hope, will result in stronger financial arrangements (no more quickie finance deals that crush current shareholders please!) and credible PRs with specific details about progress.
I know partnerships and progress take time, and I, and many other shareholders I imagine, are willingly to give that time as long as management promotes more confidence than questions. I still maintain all of my shares and plan to add a few more.
Thanks again EiK for the insight. Also, congrats on the news I believe is pending. If what I think is happening actually happens, I will have even greater confidence in NNLX management.
Being from PA, the forecasted weather was another key reason I could not attend the meeting. Workwise, I could not afford the risk of being stuck in airports for a few days.
Therefore, be safe and thanks for the promised updates when you return home. Seeing as only a few shareholders were able to attend the meeting, the "non-attendees" are now relying on those few who attended or NNLX's PRs to provide the specific insight we are seeking.
With that in mind, I sincerely hope the management at NNLX plans to issue a PR (or even a new proxy) that clarifies some specifics regarding the biomedical spinoff, audit status, 2007 goals, and hopefully partnerships!
Great call Dennis.
The recent PR seems to support your theory about the engines being stationary:
"NanoLogix, Inc. (PINKSHEETS: NNLX), an industry innovator in the research, development and commercialization of nano-biotechnologies, applications and processes, announced today the initial sale of hydrogen powered generator engines, which had been converted from gas engines."
Most generators I have been around have been stationary. This now makes much more sense to me.
In the last press release, NNLX thankfully clarified some information regarding Precision Performance Co.
"This was done in conjunction with Precision Performance Co. of Brookfield, Ohio, a private company."
This is not the same company I found on Hoovers. Ironton is in southern Ohio while Brookfield is in northeast Ohio (not too far from Erie, PA.). Also, the fact it is a private company explains why no listing was found on Hoovers.
Eik—
Thank you so much for your offer. I am sorry I could not reply sooner, but I have been quite tied up with work this week.
My questions are most likely the questions of others:
1) What are the advantages of splitting the biomedical side of NNLX into a separate OTC company? How many shares will be issued? What kind of limits will be placed to ensure gross dilution does not occur?
2) What is the status of the NNLX audit? Are there any plans to merge with Hydrogensis/Inverso?
3) Is it possible at this time to offer potential insight/numbers into the profitability of their hydrogen bioreactors?
4) When will the Erie Wastewater bioreactor be operational? I believe it was implied for the spring, but a confirmation of this would be helpful. Are other wastewater treatment plants expressing interest?
5) Can any details be offered regarding energy partnerships?
Again, many of these questions will most likely be asked, but these are a few on my mind. Also, I sincerely hope NNLX offers an efficient way to listen to and/or read information coming from the informational shareholders meeting.
Thanks again EiK.
I am in the process of tracking down more information regarding the upcoming shareholders meeting. However, I will not be able to attend myself.
Is anyone on this board planning to go? Thanks.
Best of luck to you Harry. :)
I understand why some investors would want to sell, and I sincerely wish you the best.
As for me, I still believe there is so much potential with NNLX technology, and I do not plan to sell any shares at this time. It will be very interesting to hear what comes out of the Jan 12th meeting (the "delayed" vote was a welcome acknowledgement of shareholder concern regarding the lack of proper information).
Do your own DD.
OT--
"ps. I grew up in santa cruz.... OURWORLDENT does it have anything to do with world entertainment war the band?I was a friend of Anthony Guess,George Earth ect...."
Actually, I've never heard of that band. :)
I just searched through Hoovers, which contains Dun and Bradstreet information. Only one company by that name appeared in Ohio:
Precision Performance, Llc
Ironton, OH 45638-1123
The business description is as follows:
DATA/INFORMATION FLOW SYSTEMS
CREATION/ACCESSIBILITY QUALITY CONSULTING
MANAGEMENT/SUPERVISION CONSULTING/TRAINING
Key Numbers
Annual Sales (mil.) $0.1
Total Employees 2
Employees At This Location 2
Again, I am not sure this is the company, but it is the only one I found matching what was stated in the PR.
EiK and Ted--
Thank you for the informative and thoughtful posts. These are very helpful in a time when details are sketchy. There is little I can add at this time other than to say that I have been vocal about wanting to hear news that follows through on stated promises over the last year. For better or worse, it seems news is on its way.
I completely agree with EiK that separating the company results in "stripping" NNLX of the medical patents (its only "proven" worth at this time). However, could this be due to greater advancements made in the biomedical aspect of the company than were anticipated? There were hints of this in the recent interviews.
Again, I thank all who are taking the time to contribute their thoughts and knowledge to this board. That is needed in times like these.
Interesting progression.
While I agree that this deal needs to be more specifically stated (not knowing the amount of shares to be issued is a substantial concern), I believe the overall logic of splitting off the medical and energy portions of the company could be solid.
NNLX was primarily a biomedical company that happened to stumble on a very efficient way of producing/capturing hydrogen. With that said, it makes sense to separate the two core focuses of the company. This also allows part of the split company to operate on the OTCBB. Since the hydrogen part of the company is still in the very developmental stages, this would, in turn, allow more time to devise how to handle that listing (thus the AMEX vs. OTCBB comments).
Please note that this is all speculation on my part since no substantial PRs have been issued (which might change soon--for better or worse).
As two last questions—
Could it be that while the stockholders' focus has been on the hydrogen side of NNLX more progress than anticipated has been made on the biomedical side?
Also, could Cavallo and Rivers be preparing to take over other roles within the split off company or within NNLX itself? Any thoughts on why they would be removed from the board?
Thoughtful comments on welcome.
Dennis--
I have respected your posts and your research, and I have been following and investing in this company for over a year. With this in mind, "instant gratification" is not a concern of mine.
However, the accountability of management in a pinksheet company most certainly is a concern since scams run rampant in pinksheet listings. I think NNLX is a gem within the pinks; however, promises only hold credibility for so long.
That is not impatience but rather that is logic.
Luke--
If your post is in reference to my recent posts, let me clarify I am sure we have very little in common, and my posts are not meant to be "bashes," unlike many of your posts.
I am simply noting that there needs to be proof of some promises being fulfilled or the stock price will continue to stagnate. Rest assured, however, there is wonderful potential in this company or else I would not have invested any money.
"The management of the company has no effect on the motivations of the seller, so your statement regarding them 'allowing' the sellers actions is inaccurate. They cannot do anything, another's actions are just a fact of life and market forces of one sort or another."
I completely agree that management has no control regarding individual buyers' or sellers' actions. However, there was a much greater point in my post, which does directly reflect the responsibility of management. Interviews stating what plans are being made, hiring new consultants, etc. show work is being done; however, releasing substantial PRs regarding the fulfillment of those "promises" is the only way management of a pinksheet company can prove credibility. Period.
By not releasing substantial and promised information and with the average daily volume being low, it "allows" a large seller to "control" the stock price. There's no mystery in that.
Again, I understand the potential of NNLX, but management needs to show shareholders and potential shareholders that promises made (some a year old by now) are being fulfilled.
That's just an honest shareholder's opinion.
Thanks for this helpful information. Your posts, as always, are insightful.
It seems news is in the pipeline and with any substantial PR (biotech, OTCBB, or alternate fuel partnerships), this should cause an increase in the average daily trading volume.
I hold over 100,000 shares and I am relatively patient. However, the only way management can prove itself to pinksheet shareholders is to follow through on its promises. The lack of substantial PRs and allowing one individual to control the stock price for "a month or more" does not promote confidence.
A substantial PR is needed soon, in my humble opinion.
"So short of a move to the BB or another respectable exchange, this company, like all Pinkies, can only be judged on how management has fulfilled its promises."
This is very well stated, and it is also why it is so important for NNLX to move from the pinks. I was impressed to read some discussion of an AMEX listing, but with NNLX's stated practice of holding PRs until the exchange switch is made, I question how the stock price will reach the $3.00 needed to make this happen. Chatterton’s involvement might be part of this strategy, but an OTC BB listing seems more likely at this time.
During the past several months, I have gained more respect for the management at NNLX. Early in the year, the overly positive PRs predicting the "end of fossil fuel dependence" seemed like a typical pink sheet ploy designed to pump the stock. Additionally, I was not thrilled to see financing from the Nutmeg Group (a bit of research will most likely explain my feelings toward this). Although I have no way of proving it, my hunch is that the Nutmeg Group has already sold many, if not all, of their shares.
The tone of the more recent PRs, the financing with another investment group who does not want to sell shares under $1.00, and the addition of some key players (consultants and board members) have brought new encouragement to me. This company is acting as if it is poised for bigger things in the future. Thus, I have slightly increased my shares of late.
That being said, my patience for specific news is running thin. I am willing, however, to be patient awhile longer.
First of all, I thank energyisking and several other posters who clearly want to engage in an educated dialogue about NNLX and alternative fuels for the future. I do not post often, but I have followed NNLX since early last year and own a respectable amount of shares.
It seems that investors are understandably overzealous at this point to gain more information. While making inappropriate contact with current clients and/or potential clients is not acceptable (and at worst detrimental), part of this temptation is the result of limited specific information being presented to the investing public. The promised move from the pinks and potential corporate partnerships/alliances have been promised for nearly a year now. Regardless of whether or not the initial PRs were released early, the fact remains that stockholders have been waiting for specific news in those areas for nearly a year.
I like what I know of NNLX's story and have posted positively about this company on this board and on www.thelion.com board. However, until more transparency is offered, the overzealousness caused by certain posters (some well intentioned, such as the Alcoa engineer, and some ill intentioned, such as youhadmeatmello) will most likely continue.
Still looking for that SB-10... :)
Finally!
Here is a much-needed press release about their goals to obtain a fully reporting status. That 10-SB must still be on its way.
I am also pleased that the NNLX story will be told. It needs to be told to potential investors.
Press Release Source: NanoLogix, Inc.
NanoLogix Retains OTC Financial Network for Comprehensive Investor Relations Campaign
Monday July 24, 3:39 pm ET
SHARON, Pa., July 24 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (OTC Pink Sheets: NNLX - News), a nano-biotechnology company engaged in the development and commercialization of technologies for the creation of hydrogen bioreactors, today announced that it has retained OTC Financial Network, a division of National Financial Communications Corp. ("NFC"), for a comprehensive investor relations campaign.
ADVERTISEMENT
Geoffrey Eiten, president of NFC, stated, "NanoLogix is an exciting new issue that is poised to bring to market a vast number of applications within the nano-biotechnology industry. NanoLogix has 31 issued patents with applications in nanotechnology, hydrogen gas production, medical drugs/devices, bio-defense sensors and bioremediation."
Eiten added, "The Company's current focus - converting wastewater into hydrogen to create renewable energy sources - has led to a major agreement with The Erie Wastewater Treatment Plant to convert municipal sewer water into energy. With this initial project underway, NanoLogix stands to market their innovative solutions to other municipalities and corporations seeking to combat skyrocketing oil and gas prices, and reduce their dependency on foreign energy sources."
Mitchell S. Felder, M.D., CEO of NanoLogix, Inc., stated, "Although we are in our early stages of development, we have a strong intellectual property position which we will continue to leverage to expedite the commercialization of new environmentally-friendly processes. We believe now is the right time to tell investors our story. We have entered into a partnership with OTC Financial Network to introduce our company and communicate our key corporate developments to Wall Street, with a near-term goal to becoming a fully reporting company."
About OTC Financial Network
OTC Financial Network is a leading provider of investor relations and financial consulting services and customized, proactive investor relations campaigns to more than 500 small/micro-cap public companies since 1992. A partnership with OTC Financial Network can improve a company's shareholder communications channel, facilitate capital formation opportunities, create an expanding and diversified base of institutional and retail shareholders, and garner financial media coverage. OTC Financial Network is a division of National Financial Communications Corp. based in Needham, MA. For more information, visit http://www.otcfn.com or http://www.nationalfc.com.
About NanoLogix, Inc.
NanoLogix is a nano-biotechnology company whose extensive portfolio of patents have application and marketability in the following areas: nanoscale microfluidics for the rapid identification of disease causing pathogens utilizing BioMEMS; production of high value hydrogen from agricultural feedstock, industrial waste water and municipal waste streams; nontoxic induction of apoptosis (a method for inducing a genetically based induction of "cell suicide") in cancer cells utilizing hydrophobic hydrocarbons; and the bio-remediation of air, water and soils of harmful contaminants. For more information, visit http://www.nanologix.com.
Disclaimer: OTC Financial Network, a division of National Financial Communications Corp., serves as special advisor to NanoLogix, Inc. and has received fees for services, in the amount of ninety thousand dollars for one year of service, payable in restricted shares plus an option to purchase an aggregate of five hundred thousand shares of restricted common stock at an exercise price of forty cents per share, plus expenses, for the creation and distribution of materials. This is not an offer to buy or sell securities. Information or opinions in this release are presented solely for informative purposes, and are not intended nor should they be construed as investment advice. Additional compensation information and a full disclaimer can be found online by visiting http://www.otcfn.com/nnlx and selecting the "Disclaimer" link.
This press release contains statements, which may constitute "forward- looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
Contact:
At OTC Financial Network
Geoffrey Eiten
Investor Relations
781-444-6100x613
geiten@otcfn.com
www.otcfn.com/nnlx